The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering

Nature Clinical Practice Nephrology

Volumn 2, Issue 10, 2006, Pages 542-543

  Bidani, Anil K ^a   Griffin, Karen A ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Mental Health Service Line   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMLODIPINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRBESARTAN; METOPROLOL; RAMIPRIL; THIAZIDE DIURETIC AGENT;

AUTOREGULATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; TELEMETRY;

ANGIOTENSINS; BLOOD PRESSURE; HUMANS; HYPERTENSION; RENIN; RENIN-ANGIOTENSIN SYSTEM; RESEARCH DESIGN;

EID: 33749076288     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0299     Document Type: Short Survey

References (10)

1. Bidani AK and Griffin KA (2004) Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44: 595-601
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2981-2997
3. Chobanian AV et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572
4. Casas JP et al. (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366: 2026-2033
5. Griffin KA and Bidani AK (2006) Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Clin J Am Soc Nephrol 1: 1054-1065
6. Griffin KA et al. (1995) Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96: 793-800
7. Kurtz TW et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 45: 299-310
8. Bidani AK et al. (2000) Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation. Kidney Int 57: 1651-1661
9. Griffin KA et al. (2003) Renoprotection by ACE inhibition or aldosterone blockade is blood-pressure dependent. Hypertension 41: 201-206
10. Crowley SD et al. (2005) A major role for the kidney in the pathogenesis of angiotensin II-dependent hypertension [abstract #TH-PO200]. J Am Soc Nephrol 16: 162A